|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: April 2024
Volume 9 | Issue 4
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 95
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Recent Therapeutic Status of Photodynamic Therapy for the Treatment and Diagnosis of Cancer |
| Authors Name: | Pratikeswar panda , RajaramMohapatra , SudhansuSekhar Rout , Abhijeet Mohanty , Dr. Rajaram Mohapatra |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_185600
|
| Published Paper Id: | IJNRD2301041 |
| Published In: | Volume 8 Issue 1, January-2023 |
| DOI: | |
| Abstract: | Photodynamic therapy (PDT) is a cancer and infectious illness therapy that uses reactive oxygen species (ROS) are produced by light and a photosensitizer to cause cellular damage. In this review, we focus on recent advancements of PDT and how they may be manipulated to improve clinical outcome in cancer patients. PDT has demonstrated a promising translation into cancer therapeutics when combined with chemotherapy, PTT and immunotherapy. Additionally, PDT is being used to treat bacterial infections in order to combat antibiotic resistance. We have now covered the new paths PDT is taking in the treatment of infectious and cancerous disorders. In summary, we think that the development of PDT for cancer may be greatly influenced by advancements in nanomaterials and thoughtful design. |
| Keywords: | Photodynamic therapy (PDT), oxygen species (ROS), translation, chemotherapy, immunotherapy, antibiotic resistance |
| Cite Article: | "Recent Therapeutic Status of Photodynamic Therapy for the Treatment and Diagnosis of Cancer", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 1, page no.a345-a360, January-2023, Available :http://www.ijnrd.org/papers/IJNRD2301041.pdf |
| Downloads: | 000118759 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2301041 Registration ID: 185600 Published In: Volume 8 Issue 1, January-2023 DOI (Digital Object Identifier): Page No: a345-a360 Country: -, -, - Research Area: Engineering Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2301041 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2301041 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn